Federal Circuit Rules For Pfizer In Suit Over Norvasc Patent

Law360, New York (February 28, 2004, 12:00 AM EST) -- In a closely watched case, the U.S. Court of Appeals for the Federal Circuit has ruled that Indian generic drug manufacturer Dr Reddy's Laboratories infringed on Pfizer Pharmaceutical company's patent for the top-selling hypertension drug Norvasc.

The decision reverses an earlier ruling by a lower court in Newark, New Jersey.

The case has broad implications because Dr. Reddy's Laboratories Inc. tried to use a novel approach to make a generic version of Norvasc. The company used a different salt on its compound and claimed its drug...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.